Manning & Napier Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3.77M	Sell	271,786 -26,100	-9%	-$380K	0.04%	196
2023 Q4	$4.25M	Sell	297,886 -4,381	-1%	-$62.2K	0.05%	190
2023 Q3	$4.68M	Sell	302,267 -3,189	-1%	-$49.4K	0.06%	188
2023 Q2	$4.8M	Buy	305,456 +22,939	+8%	+$376K	0.05%	196
2023 Q1	$4.66M	Sell	282,517 -7,646	-3%	-$122K	0.05%	218
2022 Q4	$4.53M	Sell	290,163 -5,543	-2%	-$77.4K	0.06%	218
2022 Q3	$3.83M	Buy	295,706 +907	+0.3%	+$12.6K	0.05%	232
2022 Q2	$4.14M	Buy	294,799 +3,397	+1%	+$48.5K	0.05%	232
2022 Q1	$4.17M	Sell	291,402 -27,903	-9%	-$410K	0.04%	237
2021 Q4	$4.35M	Sell	319,305 -2,717	-0.8%	-$38.1K	0.04%	243
2021 Q3	$5.27M	Sell	322,022 -2,207	-0.7%	-$37K	0.05%	226
2021 Q2	$5.46M	Buy	+324,229	New	+$5.52M	0.04%	235